Ozempic, Mounjaro and other weight loss drugs can have nasty side effects, and reducing the volume of food you eat will also ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...

Understanding the right dose of Ozempic for you can feel a bit confusing, especially if you’re just getting started. While ...